Location New City, New York, United States Regions Greater New York Area, East Coast, Northeastern US Gender Male
LinkedIn View on LinkedIn
Dr. Stephen Cunningham is a 25 year pharmaceutical veteran who has led teams that delivered on the development, regulatory approvals and launch of numerous significant products to improve patient health. He has global experience leading cross-functional teams from Phase 1 through life cycle management in the areas of Neuroscience, Cardiovascular,
Metabolism, Respiratory, Immunology, Oncology, Women’s Health, Transplant and Clinical Pharmacology.
During his career, Stephen lead and developed diverse cross-functional teams in Europe, Japan, Asia, Canada and the United States and has broad and deep experience in setting strategic direction, delivering projects, restructuring organizations and implementing transformational organization change. Stephen started his career at ICI Pharmaceuticals, holding global positions of increasing responsibility at ICI, Zeneca then Novartis. After joining Novartis in 2000 as Head of Medical Affairs in the US, Stephen quickly assumed the role of Chief Scientific Officer and Head of US Clinical Development, Medical Affairs and Evidence-Based Medicine in 2001.
While at Novartis he built a world-class Novartis US Clinical Development and Medical Affairs organization supporting drug development, launch and life cycle management of products worldwide. Since 2014, Stephen has worked with venture capital, as a strategic consultant and as an independent board director.
